Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. Wegleiter
Long-Term Consequences of Fetal Angiotensin II Receptor Antagonist Exposure
Case Reports in Pediatrics
Related publications
Long-Term Effects of Angiotensin II Receptor Antagonist Losartan on Uric Acid Metabolism in Hyperuricemic Patients
Gout and Nucleic Acid Metabolism
Review of Long-Term Consequences of Maternal Methamphetamine Exposure
Physiological Research
Medicine
Physiology
Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Perinatal/Neonatal Case Presentation: Neonatal Acute Renal Failure Secondary to Maternal Exposure to Telmisartan, Angiotensin II Receptor Antagonist
Journal of Perinatology
Gynecology
Child Health
Pediatrics
Perinatology
Obstetrics
Contribution of Angiotensin Converting Enzyme Gene Polymorphism to the Action of Angiotensin II Receptor Antagonist (CS-866).
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Patient With Drug-Induced Hepatic Injury Caused by Long-Term Administration of an Angiotesin II Receptor Antagonist, Losartan
Acta Hepatologica Japonica
Hepatology
"The Compromised Fetal and Neonatal Lives and Their Possible Long-Term Consequences"
Current Pediatric Reviews
Child Health
Pediatrics
Perinatology
Antagonist Effect of a Receptor-Mimicking Peptide Encoded by Human Angiotensin II Complementary RNA
Hypertension
Internal Medicine
In Vitro Pharmacological Properties of KRH-594, a Novel Angiotensin II Type 1 Receptor Antagonist.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science